Global Product Portfolio

Below is a list of the treatments we currently offer via our Innovative Medicines Division. Visit Sandoz and Advanced Accelerator Applications to learn about our generics and radiopharmaceutical products.
Please note: Not all treatments are available in all countries.

A B C D E F G I J K L M N O P R S T U V X Z

Extavia®

interferon beta-1b
Neuroscience
Neuroscience
USA Product Site USA Finland Germany United Kingdom Poland Canada

Exjade®

deferasirox
Oncology
Oncology
Global Product Site USA Product Site USA Germany Australia United Kingdom Novartis Oncology Turkey Novartis Oncology Netherlands Austria Poland Netherlands Canada Turkey Japan

Exforge®

valsartan, amlodipine besylate
Cardiovascular, Renal and Metabolism
Established Medicines
USA Product Site USA Finland Germany Australia United Kingdom Austria Poland Netherlands Turkey

Exforge HCT®

valsartan, amlodipine besylate, hydrochlorothiazide
Cardiovascular, Renal and Metabolism
Established Medicines
USA Product Site USA Finland Germany Australia Austria Poland Turkey Japan

Exelon®

rivastigmine
Neuroscience
Established Medicines
USA Finland Germany Australia United Kingdom Austria Poland Netherlands Canada Turkey Japan

Eucreas®

vildagliptin, metformin
Cardiovascular, Renal and Metabolism
Respiratory
Global Product Site Finland United Kingdom Austria Poland Netherlands

Entresto®

sacubitril, valsartan
Cardiovascular, Renal and Metabolism
Cardiovascular, Renal and Metabolism
USA Product Site USA Finland Germany Australia United Kingdom Austria Poland Netherlands Canada

Egaten®

triclabendazole
Hepatology
Established Medicines
USA